Showing results (101-110 of 482) with videos related to
Sort By:
Pageof 49
Alzheimer Disease and Associated Disorders|June 18, 2010
Luteinizing-hormone releasing hormone therapy and the risk of death from Alzheimer diseaseAnthony V D'Amico, Michelle H Braccioforte, Brian J Moran, et al.Molecular Biology and Evolution|August 31, 2010
Choosing among partition models in Bayesian phylogeneticsYu Fan, Rui Wu, Ming-Hui Chen, et al.BMC Bioinformatics|August 8, 2015
Confident difference criterion: a new Bayesian differentially expressed gene selection algorithm with applicationsFang Yu, Ming-Hui Chen, Lynn Kuo, et al.JAMA|October 4, 2007
PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5Abhijit A Patel, Ming-Hui Chen, Andrew A Renshaw, et al.Biometrics|July 22, 2014
Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndromeMing-Hui Chen, Joseph G Ibrahim, Donglin Zeng, et al.Systematic Biology|November 7, 2013
Posterior predictive Bayesian phylogenetic model selectionPaul O Lewis, Wangang Xie, Ming-Hui Chen, et al.Journal of the Korean Statistical Society|October 19, 2020
Inflated Density Ratio and Its Variation and Generalization for Computing Marginal LikelihoodsYu-Bo Wang, Ming-Hui Chen, Wei Shi, et al.European Urology Oncology|July 3, 2024
Mortality Risk for Patients with Biopsy Gleason Grade Group 1 Prostate CancerDerya Tilki, Ming-Hui Chen, Hartwig Huland, et al.Statistics in Medicine|November 14, 2018
Flexible longitudinal linear mixed models for multiple censored responses dataVictor H Lachos, Larissa A Matos, Luis M Castro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Identifying patients at risk for significant versus clinically insignificant postoperative prostate-specific antigen failureAnthony V D'Amico, Ming-Hui Chen, Kimberly A Roehl, et al.Pageof 49